| Disease manifestations and pathogenic mechanisms of group A Streptococcus MJ Walker, TC Barnett, JD McArthur, JN Cole, CM Gillen, A Henningham, ... Clinical microbiology reviews 27 (2), 264-301, 2014 | 923 | 2014 |
| DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection MJ Walker, A Hollands, ML Sanderson-Smith, JN Cole, JK Kirk, ... Nature medicine 13 (8), 981-985, 2007 | 454 | 2007 |
| A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development M Sanderson-Smith, DMP De Oliveira, J Guglielmini, DJ McMillan, T Vu, ... The Journal of infectious diseases 210 (8), 1325-1338, 2014 | 315 | 2014 |
| The Classical Lancefield Antigen of Group A Streptococcus Is a Virulence Determinant with Implications for Vaccine Design NM van Sorge, JN Cole, K Kuipers, A Henningham, RK Aziz, ... Cell host & microbe 15 (6), 729-740, 2014 | 141 | 2014 |
| Streptococcal toxins: role in pathogenesis and disease TC Barnett, JN Cole, T Rivera‐Hernandez, A Henningham, JC Paton, ... Cellular microbiology 17 (12), 1721-1741, 2015 | 124 | 2015 |
| Pathogenesis of group A streptococcal infections A Henningham, TC Barnett, PG Maamary, MJ Walker Discovery medicine 13 (72), 329-342, 2012 | 108 | 2012 |
| Mechanisms of group A Streptococcus resistance to reactive oxygen species A Henningham, S Döhrmann, V Nizet, JN Cole FEMS microbiology reviews 39 (4), 488-508, 2015 | 89 | 2015 |
| Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation I Secundino, A Lizcano, KM Roupé, X Wang, JN Cole, J Olson, SR Ali, ... Journal of Molecular Medicine 94 (2), 219-233, 2016 | 85 | 2016 |
| Conserved anchorless surface proteins as group A streptococcal vaccine candidates A Henningham, E Chiarot, CM Gillen, JN Cole, M Rohde, M Fulde, ... Journal of molecular medicine 90 (10), 1197-1207, 2012 | 67 | 2012 |
| Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone PG Maamary, NLB Zakour, JN Cole, A Hollands, RK Aziz, TC Barnett, ... The FASEB Journal 26 (11), 4675-4684, 2012 | 66 | 2012 |
| Human pathogenic streptococcal proteomics and vaccine development JN Cole, A Henningham, CM Gillen, V Ramachandran, MJ Walker Proteomics-Clinical Applications 2 (3), 387-410, 2008 | 63 | 2008 |
| Role of group A Streptococcus HtrA in the maturation of SpeB protease JN Cole, JA Aquilina, PG Hains, A Henningham, KS Sriprakash, ... Proteomics 7 (24), 4488-4498, 2007 | 57 | 2007 |
| RESEARCH ARTICLE Role of group A Streptococcus HtrA in the maturation of SpeB protease JN Cole, JA Aquilina, PG Hains, A Henningham, KS Sriprakash, ... | 57* | 2007 |
| Differing efficacies of lead group A Streptococcal vaccine candidates and full-length m protein in cutaneous and invasive disease models T Rivera-Hernandez, M Pandey, A Henningham, J Cole, B Choudhury, ... MBio 7 (3), e00618-16, 2016 | 56 | 2016 |
| Group A streptococcal vaccine candidates: potential for the development of a human vaccine A Henningham, CM Gillen, MJ Walker Host-Pathogen Interactions in Streptococcal Diseases, 207-242, 2012 | 56 | 2012 |
| Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A Streptococcus A Henningham, M Yamaguchi, RK Aziz, K Kuipers, CZ Buffalo, S Dahesh, ... Journal of Biological Chemistry 289 (46), 32303-32315, 2014 | 46 | 2014 |
| Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein MJ Bauer, MM Georgousakis, T Vu, A Henningham, A Hofmann, M Rettel, ... Vaccine 30 (12), 2197-2205, 2012 | 43 | 2012 |
| Coiled-coil destabilizing residues in the group A Streptococcus M1 protein are required for functional interaction CM Stewart, CZ Buffalo, JA Valderrama, A Henningham, JN Cole, V Nizet, ... Proceedings of the National Academy of Sciences 113 (34), 9515-9520, 2016 | 39 | 2016 |
| An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system PM Moyle, J Hartas, A Henningham, MR Batzloff, MF Good, I Toth Nanomedicine: Nanotechnology, Biology and Medicine 9 (7), 935-944, 2013 | 33 | 2013 |
| Structure-informed design of an enzymatically inactive vaccine component for group A Streptococcus A Henningham, DJ Ericsson, K Langer, LW Casey, B Jovcevski, ... MBio 4 (4), e00509-13, 2013 | 26 | 2013 |
